Skip to main
MDT

Medtronic (MDT) Stock Forecast & Price Target

Medtronic (MDT) Analyst Ratings

Based on 21 analyst ratings
Buy
Strong Buy 33%
Buy 38%
Hold 29%
Sell 0%
Strong Sell 0%

Bulls say

Medtronic is a strong investment opportunity due to its diverse portfolio, historical and projected financial performance, and progress in multiple areas such as product approvals and strategic investments for future growth. Despite short-term concerns such as competition and market conditions, MDT's strong fundamentals and positive outlook make it a compelling choice for investors. The company's stock has a Buy rating and is expected to continue its upward trajectory in the long term.

Bears say

Medtronic is facing several challenges in its major markets, notably in its Neurovascular and Neuromodulation segments, which have seen slower growth due to intense competition and limited innovation. Moreover, its recent M&A and strategic investments, while potentially driving future growth, also raise questions about the durability and confidence in its current products and technologies. Given these headwinds and uncertainties, the negative outlook on Medtronic's stock is warranted, with a potential decline in future revenues and potential risks to its P/E multiple expansion.

Medtronic (MDT) has been analyzed by 21 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 38% recommend Buy, 29% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Medtronic and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Medtronic (MDT) Forecast

Analysts have given Medtronic (MDT) a Buy based on their latest research and market trends.

According to 21 analysts, Medtronic (MDT) has a Buy consensus rating as of Sep 15, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $104.86, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $104.86, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Medtronic (MDT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.